BioFire Defense

10/21/2026

Respiratory season surges create immediate bottlenecks in military clinics and urgent care centers. The BIOFIRE® SPOTFIRE® System provides fast, multiplex PCR diagnostic results right at the point of care, detecting up to 15 respiratory targets in about 15 minutes.

Delivering fast diagnostic clarity from a single swab helps healthcare providers optimize triage, avoid unnecessary broad-spectrum antibiotic usage, and return service members to active duty without delay.

10/19/2026

Multi-vendor diagnostic procurement introduces administrative friction, logistics delays, and supply chain risk when clinical demand spikes. Standardizing with BioFire Defense simplifies ordering while protecting force health across all defense health networks.

As the sole supplier of the BIOFIRE® portfolio to the U.S. Department of War and federal agencies, BioFire Defense delivers unbroken supply security, direct technical support, and fast testing capabilities to military treatment facilities nationwide. Streamline your facility's diagnostic supply chain before peak surge season arrives.

Contact us to learn more about sole-source procurement integration: https://biofiredefense.com/contact-us/

10/19/2026

When patients who have had contact with high-consequence pathogens present with fever, medical teams need fast differential diagnosis to guide immediate containment. Building on a shared legacy supporting global Ebola response efforts with bioMérieux, BioFire Defense is expanding diagnostic capabilities with Emergency Use Authorization for the BIOFIRE® Global Fever Special Pathogens (GF SP) Panel.

The BIOFIRE GF SP Panel delivers fast, accurate multiplex PCR results from a single blood sample — targeting Ebola Virus and several other viral, bacterial, and parasitic biothreats simultaneously to eliminate diagnostic guesswork.

Read the official press release to learn more:

10/16/2026

As fall respiratory surges hit military clinics, slow diagnostic results can quickly stall care. Telling the difference between the Flu, RSV, and COVID-19 prevents diagnostic delays and keeps service members healthy and on duty.

The BIOFIRE® SPOTFIRE® System uses the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to test for up to 15 common viral and bacterial causes at once. From a single swab, clinical teams get fast, accurate PCR results in about 15 minutes to make timely treatment decisions.

BioFire Defense is proud to be the sole supplier of the BIOFIRE® portfolio to the U.S. Department of War and other federal agencies, helping military clinics simplify care, speed up patient visits, and protect unit readiness all season long.

See how the BIOFIRE SPOTFIRE System works at the point of care: https://biofiredefense.com/biofire-spotfire/

10/15/2026

Pneumonic plague remains one of the most severe and rapidly progressing biothreats due to its potential for aerosol transmission and short incubation period. Caused by the bacterium Yersinia pestis, this infection can cause severe respiratory failure within 24 hours if diagnostic clarity and treatment are delayed.

While historical outbreaks highlight its severity, modern surveillance, fast PCR identification, and early antibiotic intervention remain vital tools for containing transmission before localized cases escalate. BioFire Defense supports federal public health authorities and defense health networks with advanced molecular testing capabilities engineered for high-consequence pathogen detection and force health protection.

Learn more about our specialized biodefense diagnostic solutions: https://biofiredefense.com/contact-us/

Contact Us Home Contact Us Ordering and Sales Support Domestic and Military Sales Phone: 801-262-3592 Available on E-CAT BioFire Defense Sales Team Online: Sales Team Form Phone: 801-262-3592 x6004 Technical Service and Support For SDS sheets, online product support, instructional videos, technical....

10/13/2026

We at BioFire Defense recognize 251 years of service by the U.S. Navy.
From forward-deployed ships to shore-based medical centers, Navy medical teams and corpsmen work around the clock to protect warfighter health and maintain operational readiness. BioFire Defense remains committed to supporting these personnel by delivering fast, reliable diagnostic capabilities that help medical teams make critical health decisions whenever and wherever duty calls.
We salute the men and women of the U.S. Navy for their steadfast service to our nation.
Semper Fortis.

10/09/2026

When samples from severe respiratory cases reach hospital labs, running single tests one at a time slows down care and leaves doctors waiting for answers. Lab managers need a practical way to check for multiple causes at once so providers can treat patients accurately without delay.

The BIOFIRE® TORCH System runs the BIOFIRE® Respiratory 2.1 (RP2.1) Panel and BIOFIRE® FILMARRAY® Pneumonia (PN) Panel to identify a wide range of viruses, bacteria, and antimicrobial resistance genes in about an hour. Backed by bioMérieux technology, standardizing central labs on one platform helps military hospitals target treatments faster, avoid unnecessary antibiotic use, and manage seasonal surges smoothly.

Learn more about high-volume lab testing with BioFire Defense: https://biofiredefense.com/filmarray-torch-system/

10/06/2026

For Military Treatment Facility (MTF) clinical care providers and lab directors managing high patient volume during respiratory season, fast diagnostic turnaround directly dictates facility throughput and force readiness.
Swipe through our educational guide to see how the BIOFIRE® SPOTFIRE® System transforms seasonal respiratory triage. By delivering lab-grade multiplex PCR results in about 15 minutes right at the point of care, SPOTFIRE reducing diagnostic guesswork, empowering MTF clinicians to isolate infectious patients quickly, discharge low-risk cases confidently, and initiate targeted antiviral or antibacterial therapy on the spot.
Streamline your facility's respiratory workflow before seasonal surges peak:
https://biofiredefense.com/biofire-spotfire/

10/02/2026

When infectious diseases strike, healthcare teams need fast answers to stop transmission.

Join BioFire Defense CEO John D. Harris, MBA at BioHive Premieres at the Gateway Megaplex Theaters for his presentation, "REFUSE TO GUESS – Syndromic Testing from Utah to the Front Line." Featured in the BioDefense Track hosted by 47G, his talk explores how syndromic testing bridges from high-consequence biodefense roots like the BioFire® Global Fever Special Pathogens (GF SP) Panel during the Ebola response to frontline outbreak control with WATCHFIRE.

Backed by bioMérieux, BioFire Defense equips defense health networks and government partners with the trusted tools needed to reduce diagnostic guesswork.

Learn more about the event here: https://www.biohive.com/biohivepremieres/

10/01/2026

As the respiratory season begins, military treatment facilities and decentralized clinics face an immediate influx of service members and dependents presenting with overlapping symptoms.

BioFire Defense is proud to be the sole supplier of the BIOFIRE® portfolio of multiplex PCR diagnostic tests to the Department of War and other U.S. Government Agencies.

Backed by bioMérieux, BioFire Defense scales syndromic molecular testing across every level of military care. Frontline clinics utilize the BIOFIRE® SPOTFIRE® System and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to deliver fast, accurate answers for 15 targets in about 15 minutes. Central labs rely on the BIOFIRE® TORCH System running the BIOFIRE® Respiratory 2.1 (RP2.1) Panel and BIOFIRE® FILMARRAY® Pneumonia (PN) Panel for broad molecular results in about an hour.

Standardizing on the BIOFIRE platform eliminates diagnostic guesswork, maximizes diagnostic yield, and protects force readiness all season long.

Learn how the bioMérieux and BioFire Defense ecosystem supports respiratory readiness across military health networks: http://biofiredefense.com/biofire-spotfire/